Paid Drug Addiction Clinical Trials

Candace Kastanis

Written by Candace Kastanis

Chemistry B.S. | UC Davis | Clinical Lab Technician

Updated & Fact Checked 3/07/23

What is a paid drug addiction clinical trial?

Paid drug addiction trials are clinical studies that focus on understanding the biological nature of advanced substance abuse and viable drug candidates that may assist drug cessation. In many cases, patients who are heavily involved in substance abuse have tried a myriad of treatments to help them quit. Additionally, scientists conclude addiction may be partly hereditary in nature.

Therefore, researchers conduct paid drug addiction trials to test out treatments to aid withdrawal and to curb cravings. They also sometimes pair behavioral modification treatments in conjunction with drug therapies so there is much to be discovered in this arena. The participants are compensated for taking part in these therapies so often these paid clinical trials offer a nice reprieve for affected patients.

How do I find the paid drug addiction clinical trials near me?

There are several avenues to finding a paid clinical trial specifically targeting substance abuse in your local area. We suggest you start by communicating interest with your personal physician. He or she may be able to assist in finding a study appropriate for your specific needs. Other ways of finding paid clinical trials near you can be found on most government websites and some research-based institutions. It may be worthwhile to also visit your local drug abuse treatment center for more information clinical trials in your area.

Who conducts clinicals trials relating to substance abuse?

Most paid vaccine trials are hosted by the pharmaceutical companies in charge of vaccine development. They routinely develop improved and new vaccine products and rely upon successful human clinical trials to receive FDA approval. By enlisting the help of paid participants, they can better assess how ready their product is to enter the clinical marketplace.


What are the advantages of participating in paid drug addiction clinical trials?

The advantages of participating in a paid substance abuse specific clinical trial may assist in receiving specialized drug treatments and options. The key advantage rests the fact that you would not have any associated out of pocket costs for receiving high-value care and treatment. Rehabilitation centers specializing in drug addiction can cost thousands of dollars, putting it out of reach for many. You may meet others who share similar afflictions, and your participation mayfacilitate access to support groups and resources.


What are the disadvantages of participating in paid drug addiction trials?

Participating in a paid addiction trial may present some personal discomfort both emotionally and physically. The process of receiving treatment may also present you with some measurable inconvenience with respect to attending check-ins for vital signs, mandatory therapies, and testing, and the like. Moreso, the intervention therapy may not work as intended.


How do paid addiction trials work?

Paid addiction clinical trials are part of a more aggressive campaign towards Harm Reduction efforts. To help in the recovery process, paid initiatives such as contingency management, and paid clinical trials contribute towards overall wellness and sobriety. The eligibility criteria may vary depending upon the clinical sponsor, but the process of participation may involve medication adherence, and behavioral modification therapy to receive full payment.

Phase I Paid Clinical Trials

Phase I clinical trial seek to determine the safest dose to achieve the best possible outcome. They also assess the safety of the chosen therapeutic modality.

Phase II Paid Clinical Trials

The phase two clinical trial process involves an expanded effort of phase 1 objectives. The aim is to determineoptimal dosage routes of administration.

Phase III Paid Clinical Trials

Phase III clinical trials determines the potential for adverse reactions. At this trial phase, it is common for research investigators to examine the effects on various sub-populations and how a treatment plan benefits a patient compared to other drug candidates or combinations.

Phase IV Paid Clinical Trials

Phase four, the past part of the clinical trial process, aims to test the intervention against the current standard of care. Clinical investigators are also seeking to narrow the toxicity profiles, or any potential safety concerns that may prohibit a successful launch to market.


What do researchers learn from conducting paid drug addiction clinical trials?

Researchers learn a great deal from conducting paid drug addiction clinical trials. Approximately 20 million individuals (The population of New York) in the US are battling some form of substance abuse.

Previous clinical studies reflect that substance abuse tends to coincide with other disorders. Substance abuse is a precursor to systemic diseases such as cancer, diabetes, congestive heart failure, and kidney disease.

Researchers seek more effective treatment options that help with withdrawal, desire, and post-addiction needs. The hope is that paid volunteers continue to enroll in these programs so that we can find viable solutions to help on a national scale.

The Statistics on Drug Addiction (Source: American Addiction Centers)

  • According to the National Survey on Drug Use and Health (NSDUH), 19.7 million American adults (aged 12 and older) battled a substance use disorder in 2017.
  • Almost 74% of adults suffering from a substance use disorder in 2017 struggled with an alcohol use disorder.
  • About 38% of adults in 2017 battled an illicit drug use disorder.
  • That same year, 1 out of every 8 adults struggled with both alcohol and drug use disorders simultaneously.
  • In 2017, 8.5 million American adults suffered from both a mental health disorder and a substance use disorder.
  • Drug abuse and addiction cost American society more than $740 billion (about $2,300 per person in the US) annually in lost workplace productivity, healthcare expenses, and crime-related costs.

Commonly Asked Questions (FAQs)

  • How much are participants compensated in paid vaccine clinical trials?

    Paid vaccine clinical trial participants may receive compensation values upwards of several hundred dollars per day for successful completion. The compensation values vary quite a bit from study to study and are dependent upon the type and clinical sponsor. Factors affecting compensation may include:

    • The number of enrollees.
    • The anticipated length of the clinical trial.
    • The location.
    • The amount of care and external support services needed.

  • How do I find out if I am eligible to participate in a paid clinical trial that focus on drug addiction?

    The eligibility criteria for paid vaccine trials vary considerably. Clinical trial sponsors look for otherwise healthy candidates who have a demonstrated history battling substance abuse. They may also possibly look at previous efforts and treatment types to see how apt you are to respond to the treatment modality being offered.

    Considerations for eligibility may pertain to:

    • Age
    • Gender
    • Geography
    • Overall health
    • Level of education
    • Length of time battling substance abuse
    • Co-disorder afflictions
    • Family history
    • Genetic precursors
    • Type of illicit drug or substance being abused
    • Behavorial/Mental health

  • Will participation in a paid clinical trial specializing in substance abuse prevent me from leaving prior to completion?

    Participation in any clinical trial is voluntary, and you are allowed to leave for any reason. Clinical trial coordinators are understanding and respectful of any choice made. However, due to the nature of the clinical trial, it may be encouraged to stick it out,ifpossible, despite any challenges.

    Common reasons cited for leaving a paid clinical trial are often because of personal hardships and extenuating personal circumstances. Other reasons may relate to unforeseen medical conditions that complicate the treatment being administered.

  • What type of information is normally collected in paid vaccine trials?

    Those interested in participating in paid vaccine trials should expect to share substantial amounts of personal information. Researchers will use the information provided to qualify you as a viable candidate.

    The clinical trial sponsors usually collect information using self-guided questionaries and surveys to help form hypotheses and validate endpoint data. Information typically collected related to:

    • Individual experiences and satisfaction
    • Health challenges because of the vaccine trial
    • Lifestyle choices
    • Drug use
    • Supplement use
    • Genetic precursors
    • Personal health values and test results

  • How long do paid vaccine trials usually last?

    Clinical trials do not have set timelines and vary from study to study. Clinical trial lengths are dependent upon a series of ongoing factors such as:

    • Patient recruitment and retention
    • Patient health
    • The type of paid clinical trial I.e., randomized, double-blind
    • Adverse health reactions or results
    • Post-clinical trial care and follow-ups

  • If I am interested in participating in a paid vaccine trial, what questions should I ask?

    Clinical trial investigators must disclose all relative information about the paid clinical trial you are enrolled in and any inherent risk factors.

    This disclosure process is called informed consent.

    The NIH maintains clear guidance for the structure and safety of clinical trial execution. There is a strict emphasis on patient safety, and as such, an informed consent disclosure must include the following information:

    1. The comprehensive nature of the treatment, procedure, or drug.
    2. Any inherent risks associated with the intended treatment methods.
    3. Reasonable alternatives to the procedure or treatment intervention.
    4. Assessment and acknowledgment that you understand items 1-3.

    Informed consent is required and articulates the agreement between you, your healthcare physician, and clinical trial sponsors. The purpose of informed consent is to provide the patient with the details of every facet of the intended clinical trial study plan. This goal of informed consent is to establish trust and confidence between the eligible participant and the clinical trial sponsor team leads.

  • What to ask:

    – Inquire as to the goals or aim of the highly paid clinical trial.
    – Ask what the likelihood of side effects may be.
    – Ask what side effects should be anticipated.
    – Ask what benefits you are entitled to such as post trial care services.
    – Clarify the type and means for any out-of-pocket expenses.
    – Clarify the exact method of compensation and timeline for payments.
    – Clarify any travel and accommodations that may be necessary and their corresponding expenses.
    – You may ask if family members may accompany you during hospital stays or doctor visits.
    – Inquire about the number of clinical visits may be expected.
    – Ask what home-care services and strategies are available during the paid clinical trial should you require more advanced care.
    – Make sure you are clear on any procedures, drug interactions, and long-term consequences associated with the trial intervention.
    – Inquire about the length of speculation of hospital stays along with any associated costs.
    – Some clinical studies are randomized trial designs where they include the use of a placebo. Therefore, asking what type of trial design and what is involved with the paid clinical study you are interested in.
    – Inquire about the endpoint findings and any access to results.
    – Inquire as to the number of patients will be recruited.